Novel neutralizing SARS-CoV-2-specific mAbs offer detection of RBD linear epitopes

🔗 Access full article via BMC Virology Journal

To stop the spread of the COVID-19 disease, it is crucial to create molecular tools to investigate and diagnose COVID-19. Current efforts focus on developing specific neutralizing monoclonal antibodies (NmAbs)…

Continue reading on BioMed Central